Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NIH expands investment to advance basic medical research toward HIV cure

July 15, 2016

Vaccine Technologies HIV vaccine LFn-p24B/C displays immunogenicity in phase I study

July 14, 2016

Gilead Sciences and Institute of Organic Chemistry and Biochemistry patent anti-HIV agents

July 12, 2016

Gilead Sciences describes HIV reverse transcriptase inhibitors

July 11, 2016

GS-9883 found to reduce HIV-1 RNA in clinical trial

July 1, 2016

GeoVax Labs receives award from NIH for HIV vaccine program for Africa

July 1, 2016

Japan Tobacco prepares launch of Genvoya combination tablets in Japan

June 30, 2016

Gilead Sciences' Odefsey approved in Europe

June 27, 2016

Merck & Co. discloses HIV integrase inhibitors

June 27, 2016

Merck & Co. discloses HIV integrase inhibitors

June 23, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...